These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27411805)

  • 41. Adipose tissue inflammation in obesity and metabolic syndrome.
    Nishimura S; Manabe I; Nagai R
    Discov Med; 2009 Aug; 8(41):55-60. PubMed ID: 19788868
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.
    Sterry W; Strober BE; Menter A;
    Br J Dermatol; 2007 Oct; 157(4):649-55. PubMed ID: 17627791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating cell-free DNA levels in Portuguese patients with psoriasis vulgaris according to severity and therapy.
    Coimbra S; Catarino C; Costa E; Oliveira H; Figueiredo A; Rocha-Pereira P; Santos-Silva A
    Br J Dermatol; 2014 Apr; 170(4):939-42. PubMed ID: 24245854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adipokines and psoriasis.
    Gerdes S; Rostami-Yazdi M; Mrowietz U
    Exp Dermatol; 2011 Feb; 20(2):81-7. PubMed ID: 21255085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Research gaps in psoriasis: opportunities for future studies.
    Ryan C; Korman NJ; Gelfand JM; Lim HW; Elmets CA; Feldman SR; Gottlieb AB; Koo JY; Lebwohl M; Leonardi CL; Van Voorhees AS; Bhushan R; Menter A
    J Am Acad Dermatol; 2014 Jan; 70(1):146-67. PubMed ID: 24126079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Childhood psoriasis].
    Mahé E; Gnossike P; Sigal ML
    Arch Pediatr; 2014 Jul; 21(7):778-86. PubMed ID: 24935452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study.
    Coimbra S; Oliveira H; Belo L; Figueiredo A; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2013 Feb; 14(1):49-53. PubMed ID: 23329079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Psoriasis and Cardiovascular Disease.
    Shahwan KT; Kimball AB
    Med Clin North Am; 2015 Nov; 99(6):1227-42. PubMed ID: 26476250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Simple obesity in children. A study on the role of nutritional factors].
    Weker H
    Med Wieku Rozwoj; 2006; 10(1):3-191. PubMed ID: 16733288
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome.
    Müller MJ; Lagerpusch M; Enderle J; Schautz B; Heller M; Bosy-Westphal A
    Obes Rev; 2012 Dec; 13 Suppl 2():6-13. PubMed ID: 23107255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse events from systemic therapies for psoriasis are common in clinical practice.
    Pearce DJ; Higgins KB; Stealey KH; Balkrishnan R; Crane MM; Camacho F; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2006; 17(5):288-93. PubMed ID: 17092859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of obesity and smoking on psoriasis presentation and management.
    Herron MD; Hinckley M; Hoffman MS; Papenfuss J; Hansen CB; Callis KP; Krueger GG
    Arch Dermatol; 2005 Dec; 141(12):1527-34. PubMed ID: 16365253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A global approach to psoriatic patients through PASI score and Skindex-29.
    Prignano F; Ruffo G; Ricceri F; Pescitelli L; Lotti T
    G Ital Dermatol Venereol; 2011 Feb; 146(1):47-52. PubMed ID: 21317856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist.
    Barrea L; Nappi F; Di Somma C; Savanelli MC; Falco A; Balato A; Balato N; Savastano S
    Int J Environ Res Public Health; 2016 Jul; 13(5):. PubMed ID: 27455297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential Immunological Links Between Psoriasis and Cardiovascular Disease.
    Sajja AP; Joshi AA; Teague HL; Dey AK; Mehta NN
    Front Immunol; 2018; 9():1234. PubMed ID: 29910818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deciphering the Association Between Psoriasis and Obesity: Current Evidence and Treatment Considerations.
    Paroutoglou K; Papadavid E; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2020 Sep; 9(3):165-178. PubMed ID: 32418186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
    Wisse BE
    J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.